HansBiomed Corporation (KOSDAQ: 042520)
South Korea
· Delayed Price · Currency is KRW
8,710.00
-190.00 (-2.13%)
Jan 21, 2025, 3:00 PM KST
HansBiomed Revenue
In the fiscal year ending September 30, 2024, HansBiomed had annual revenue of 81.14B KRW with 3.98% growth. HansBiomed had revenue of 19.51B in the quarter ending September 30, 2024, with 2.62% growth.
Revenue
81.14B
Revenue Growth
+3.98%
P/S Ratio
1.40
Revenue / Employee
638.88M
Employees
127
Market Cap
113.77B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 81.14B | 3.11B | 3.98% |
Sep 30, 2023 | 78.03B | 3.57B | 4.80% |
Sep 30, 2022 | 74.46B | 15.36B | 25.99% |
Sep 30, 2021 | 59.10B | -21.00B | -26.22% |
Sep 30, 2020 | 80.10B | 13.11B | 19.57% |
Sep 30, 2019 | Pro | Pro | Pro |
Sep 30, 2018 | Pro | Pro | Pro |
Sep 30, 2017 | Pro | Pro | Pro |
Sep 30, 2016 | Pro | Pro | Pro |
Sep 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |